Increasing Prevalence of Allergic Disorders to Boost The Allergy Immunotherapy Market Growth


Allergy Immunotherapy Market, by Treatment Type (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), by Allergy Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global Allergy Immunotherapy Market is estimated to be valued at US$ XX million in XXX and is expected to exhibit a CAGR of XX% over the forecast period, as highlighted in a new report published by Coherent Market Insights.

The global Allergy Immunotherapy Market is estimated to be valued at US$ 2,116.0 million in 2022 and expected to exhibit a CAGR of 9.3% over the forecast period (2022-2030).

Market Overview:

Allergy Immunotherapy is a preventive therapy for allergic reactions to things such as grass pollens, house dust and bee venom. Allergy Immunotherapy includes offering of gradually increasing dosages of the substance, or allergen, to which the individual is allergic. The incremental rise of the allergen results the immune system to be very less sensitive to the material, possibly by resulting in the creation of a preventing antibody, which decreases the prodromes of allergy while the material is run into future. Allergy Immunotherapy also decreases the infection that categorizes rhinitis and asthma.

Competitive Landscape:

Key players involved in the global allergy immunotherapy market are HAL Allergy Group, ALK-Abello A/S, DBV Technologies, Stallergenes Greer, Aimmune Therapeutics, Allergy Therapeutics, Allergopharma, Leti Pharma, and Jubilant HollisterStier.

Market Key Drivers:

Increasing prevalence of allergic disorders is expected to propel the growth of global allergy market. For instance, according to Asthma and Allergy Foundation of America above 25 million allergies are occurred due to rising pollen counts.

The rising incidences of allergic rhinitis is projected to boost the growth of global allergy market. For instance, as per Asthma and Allergy Foundation of America around 20 to 25% of the U.S population suffer allergic rhinitis.

Covid-19 Impact Analysis:

The Covid-19 outbreak has negatively impacted the growth of allergy market. It has been a major issue for the scientists to perform survey in the COVID-19 outbreak. People with ragweed pollen allergy are confused with the COVID-19 prodromes as the symptoms linked to both problems as same.

Key Takeaways:

The global allergy market is anticipated to exhibit a CAGR of XX % during the forecast period owing to rising R&D for the expansion of immunotherapy medicines againsrt the food allergies. For instance, Aimmune Therapeutics is innovating an analyzed biologic immunotherapy medicine, AR101, to overcome peanut allergy.

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in global allergy market due to rising allergy disorders, rising permission of allergy drops and rising R&D. For instance, as per EC, above 150 million Europeans are affected with allergic diseases and it is projected that above 50% of the populace in the region would suffer with at least one type of allergy by 2025.

Comments

Popular posts from this blog

Refinery Catalysts are Important Components of a Petroleum Refinery

Wearable Injector are Devices Which Adhere to the Body and Help in Administering Drug to the Patient

Global Flocculant And Coagulant Market Is Estimated To Witness High Growth Owing To Increasing Demand For Water Treatment Applications